Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Neorich Biopharma Tech Co's quarterly market cap
increased
from Dec. 2022 ($2,819.52 Mil) to Mar. 2023 ($4,365.71 Mil) but then
declined
from Mar. 2023 ($4,365.71 Mil) to Jun. 2023 ($1,623.86 Mil).
Neorich Biopharma Tech Co's annual market cap
increased
from Sep. 2020 ($15,328.96 Mil) to Sep. 2021 ($20,964.41 Mil) but then
declined
from Sep. 2021 ($20,964.41 Mil) to Sep. 2022 ($8,845.22 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Neorich Biopharma Tech Co's Enterprise Value for Today is $0.35 Mil.
Neorich Biopharma Tech Co (OTCPK:PHBID) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Neorich Biopharma Tech Co Market Cap Related Terms
Neorich Biopharma Tech Co Market Cap Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Neorich Biopharma Tech Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Neorich Biopharma Tech Co Market Cap vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Neorich Biopharma Tech Co's Market Cap distribution charts can be found below:
* The bar in red indicates where Neorich Biopharma Tech Co's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Neorich Biopharma Tech Co (PHBID) has a Market Cap of $0.35 Mil as of Aug. 13, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Neorich Biopharma Tech Co and its competitors.
Is Neorich Biopharma Tech Co's Market Cap too high?
Neorich Biopharma Tech Co's current Market Cap is $0.35 Mil. The Drug Manufacturers industry median Market Cap is 231.08. Neorich Biopharma Tech Co's value of $0.35 Mil is 99.8% below this industry median.
How does Neorich Biopharma Tech Co's Market Cap compare to DVLP and CSTF?
Neorich Biopharma Tech Co's Market Cap of $0.35 Mil can be compared against companies in the Drug Manufacturers industry. The industry median Market Cap is 231.08. Neorich Biopharma Tech Co's value of $0.35 Mil is 99.8% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Drug Manufacturers company?
The median Market Cap among Drug Manufacturers companies is 231.08, based on 1,022 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Neorich Biopharma Tech Co's current Market Cap of $0.35 Mil is 99.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Neorich Biopharma Tech Co and its competitors. For the Drug Manufacturers industry, the median Market Cap is 231.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Neorich Biopharma Tech Co's current Market Cap is $0.35 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Neorich Biopharma Tech Co stock overvalued right now?
Neorich Biopharma Tech Co (PHBID) has a current Market Cap of $0.35 Mil. The current Market Cap is $0.35 Mil and 99.8% below the Drug Manufacturers industry median of 231.08. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Neorich Biopharma Tech Co (PHBID), the current Market Cap is $0.35 Mil as of Aug. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Pharmagreen Biotech Inc is a biotech science company with specialized products and services in the cannabis industry. The company plans to produce and sell tissue culture plantlets and cannabis oil. Its line of nutraceutical products is a proprietary blend of therapeutic plants and mushrooms. It is developing its business model beyond just cannabis, and is focused on near term revenues from its proprietary blend of therapeutic plants and fungi, a nutraceutical wellness product. Utilizing the Company's expertise in plant genetics, Its transgenic program uses the newest technology available to research and create nutraceuticals, protein-based vaccines, and daily supplements with the potential to improve lives and address a wide variety of disease conditions.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PHBID has been successfully added to your 
